KAZANCI, F. Et Al. 2021. Should We Accept the HPV Type 66 into a Probable High-Risk Group? The Prevalence, Clinical and Histopathological Evaluation of HPV Type 66 in Gazi University, Ankara. GAZI MEDICAL JOURNAL , vol.32, no.1 , 98-103.

KAZANCI, F., Kocak, A. A., ÇOLAK, M., ERDEM, Ö., ONAN, M. A., & BOZDAYI, G., (2021). Should We Accept the HPV Type 66 into a Probable High-Risk Group? The Prevalence, Clinical and Histopathological Evaluation of HPV Type 66 in Gazi University, Ankara. GAZI MEDICAL JOURNAL , vol.32, no.1, 98-103.

KAZANCI, FERAH Et Al. "Should We Accept the HPV Type 66 into a Probable High-Risk Group? The Prevalence, Clinical and Histopathological Evaluation of HPV Type 66 in Gazi University, Ankara," GAZI MEDICAL JOURNAL , vol.32, no.1, 98-103, 2021

KAZANCI, FERAH Et Al. "Should We Accept the HPV Type 66 into a Probable High-Risk Group? The Prevalence, Clinical and Histopathological Evaluation of HPV Type 66 in Gazi University, Ankara." GAZI MEDICAL JOURNAL , vol.32, no.1, pp.98-103, 2021

KAZANCI, F. Et Al. (2021) . "Should We Accept the HPV Type 66 into a Probable High-Risk Group? The Prevalence, Clinical and Histopathological Evaluation of HPV Type 66 in Gazi University, Ankara." GAZI MEDICAL JOURNAL , vol.32, no.1, pp.98-103.

@article{article, author={FERAH KAZANCI Et Al. }, title={Should We Accept the HPV Type 66 into a Probable High-Risk Group? The Prevalence, Clinical and Histopathological Evaluation of HPV Type 66 in Gazi University, Ankara}, journal={GAZI MEDICAL JOURNAL}, year=2021, pages={98-103} }